ClinicalTrials.Veeva

Menu

Clinical Effectiveness of(VistaProof)in Comparison With ICDAS-II & Histological Validation for Detecting Occlusal Caries

M

Mohamed samy El-sayed

Status

Completed

Conditions

Light Fluorescence Device

Treatments

Procedure: fissurotomy
Device: vistacam proof
Other: ICDASII

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

a diagnostic accuracy study control trial is to be held to evaluate the Clinical performance of quantitative light fluorescence based device (Vistacam Proof) in comparison with the visual examination and histological validation in detection of initial pits and fissures caries

Enrollment

24 patients

Sex

All

Ages

15 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged from 15 to 50 years.
  • Patient at least has one posterior pits and fissure occlusal caries.
  • No gender restriction
  • Co-operative patients who signed the informed consent.
  • Good general health
  • Acceptable oral health

Exclusion criteria

  • Pregnancy.
  • Disabilities.
  • Systemic disease or severe medical complications.
  • Allergic history concerning methacrylate.
  • Rampant caries.

Trial design

24 participants in 3 patient groups

vistacam
Treatment:
Device: vistacam proof
ICDAS II
Treatment:
Other: ICDASII
Fissurotomy
Treatment:
Other: ICDASII
Procedure: fissurotomy
Device: vistacam proof

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems